REMEMBER

Omar Zaid
Omar Zaid
The Biopharmaceutical industry provides 75% of the FDA’s drug review Budget. Isn’t this a Problem? -- Sott.net
Caroline Chen of ProPublica has written a provocative article challenging the objectivity of the FDA in its approval of new drugs. Entitled: “FDA Repays Industry by Rushing Risky Drugs to Market”, Chen contends that the agency is beholden to the...
Science

Omar Zaid

Author, Editor, Physician & Essential Monotheist

Comments

Sign in or become a Omar Zaid member to read and leave comments.
Just enter your email below to get a log in link.